Erectile dysfunction

scientific article

Erectile dysfunction is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1056/NEJM200006153422407
P698PubMed publication ID10853004

P2093author name stringLue TF
P433issue24
P407language of work or nameEnglishQ1860
P304page(s)1802-1813
P577publication date2000-06-01
P1433published inThe New England Journal of MedicineQ582728
P1476titleErectile dysfunction.
P478volume342

Reverse relations

cites work (P2860)
Q54340037A Chinese herbal formula, Shuganyiyang capsule, improves erectile function in male rats by modulating Nos-CGMP mediators.
Q37165036A Quality Analysis of Randomized Controlled Trials about Erectile Dysfunction
Q80391804A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on the Sexual Function of Hypertensive Men
Q37820206A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction
Q44693716A classification based on peak systolic velocity and end diastolic velocity predicts sildenafil citrate success.
Q35123699A discrepancy of penile hemodynamics during visual sexual stimulation observed by near-infrared spectroscopy
Q35628328A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction.
Q43653615A new potential of blood oxygenation level dependent (BOLD) functional MRI for evaluating cerebral centers of penile erection
Q34129318A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
Q41945517A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction
Q97522072A prospective study of the effect of antihypertensive medications on the sexual functions of hypertensive adult male patients
Q24535020A role for the melanocortin 4 receptor in sexual function
Q29387552A side effect resource to capture phenotypic effects of drugs
Q34176644A simple and sensitive HPLC fluorescence method for determination of tadalafil in mouse plasma
Q48049407A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction
Q35105343A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation
Q48327568Ac-nle-c[asp-his-dphe-arg-trp-lys]-nh2 induces penile erection via brain and spinal melanocortin receptors
Q26765211Acupuncture for Erectile Dysfunction: A Systematic Review
Q35277935Acupuncture for erectile dysfunction: a systematic review protocol
Q34005421Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism
Q30234763Adipose tissue-derived stem cell therapy for erectile dysfunction in rats: a systematic review and meta-analysis
Q35750940Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction
Q64060640Administration of Adipose Derived Mesenchymal Stem Cells and Platelet Lysate in Erectile Dysfunction: A Single Center Pilot Study
Q59048530Advances in Stem Cell Therapy for Erectile Dysfunction
Q38966016Advances in pharmacotherapy for erectile dysfunction and associated cardiac impact
Q39327895Advances in the understanding of priapism
Q88945335Advantages and limitations of sleep-related erection and rigidity monitoring: a review
Q36295227Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease
Q46700660Altered expression of mitofusin 2 in penile tissues of diabetic rats
Q46803480An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy
Q28581593Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors
Q34511442Andropause: clinical implications of the decline in serum testosterone levels with aging in men.
Q35648400Andropause: endocrinology, erectile dysfunction, and prostate pathophysiology
Q37972086Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED.
Q40979087Aphrodisiac potentials of the ethanol extract of Aloe barbadensis Mill. root in male Wistar rats
Q54645716Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis.
Q36255174Assessment, diagnosis, and investigation of erectile dysfunction
Q44019807Associated factors and prevalence of erectile dysfunction in hemodialysis patients
Q46570966Association among metabolic syndrome, testosterone level and severity of erectile dysfunction.
Q91530137Association between chronic obstructive pulmonary disease and risk of erectile dysfunction: a systematic review and meta-analysis
Q41547928Association between coronary heart disease and erectile dysfunction in Chinese Han population
Q37388112Association between erectile dysfunction and coronary artery disease and its severity
Q34962528Association between renal function, erectile function and coronary artery disease: detection with coronary angiography
Q39871254Association of Urinary Phthalate Metabolites With Erectile Dysfunction in Racial and Ethnic Groups in the National Health and Nutrition Examination Survey 2001-2004.
Q89460098Associations between body mass index, waist circumference and erectile dysfunction: a systematic review and META-analysis
Q56959524Author Reply
Q38846047Avanafil - a further step to tailoring patient needs and expectations
Q38042912Avanafil for treatment of erectile dysfunction: review of its potential
Q34624315Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction
Q44322931BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo
Q51477419Beneficial effect of PEDF-transfected ADSCs on erectile dysfunction in a streptozotocin-diabetic rat model.
Q48626822Brain activation and sexual arousal in healthy, heterosexual males
Q36343594Can Erectile Dysfunction in Young Patients Serve as a Surrogate Marker for Coronary Artery Disease?
Q39775989Can simvastatin improve erectile function and health-related quality of life in men aged >40 years with erectile dysfunction? Rationale and design of the Erectile Dysfunction and Statins (EDS) Trial [ISRCTN66772971](1).
Q33506250Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men
Q44919822Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).
Q24194249Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men
Q94326362Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men
Q90737439Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis
Q41949022Cell phone usage and erectile function
Q35949480Challenges in the assessment of erectile dysfunction and treatment with oral therapies: review with case examples
Q63435728Characteristics and expectations of patients with erectile dysfunction: results of the SCORED study
Q45663668Characterization of age-related penile microvascular hemodynamic impairment using laser speckle contrast imaging: possible role of increased fibrogenesis
Q36866586Chloroquine-induced nitric oxide as a potential treatment of erectile dysfunction associated with the metabolic syndrome: the science and the fiction
Q43276188Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil
Q45926237Chronic ethanol consumption induces cavernosal smooth muscle dysfunction in rats.
Q30241531Chronic periodontitis and the risk of erectile dysfunction: a systematic review and meta-analysis
Q33710353Chuanxiongzine relaxes isolated corpus cavernosum strips and raises intracavernous pressure in rabbits
Q83365363Clinical features and treatment options for Chinese patients with severe primary erectile dysfunction
Q46652301Clinical predictive factors of sildenafil response: a penile hemodynamic study
Q26829068Clinical significance of erectile dysfunction developing after acute coronary event: exception to the rule or confirmation of the artery size hypothesis?
Q26740510Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review
Q50093996Coffee intake and incidence of erectile dysfunction
Q35166471Colour Doppler ultrasound of the penis.
Q51663469Combination Therapy Using Human Adipose-derived Stem Cells on the Cavernous Nerve and Low-energy Shockwaves on the Corpus Cavernosum in a Rat Model of Post-prostatectomy Erectile Dysfunction.
Q90524391Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil
Q34165055Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adipose-derived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction.
Q42128266Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
Q54170825Combined sildenafil with vacuum erection device therapy in the management of diabetic men with erectile dysfunction after failure of first-line sildenafil monotherapy.
Q48113809Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)/brain-derived neurotrophic factor (BDNF)-membrane system in a rat model of cavernous nerve injury
Q44229954Comment: neurologic, psychological, and aggressive disturbances with sildenafil
Q90318488Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for erectile dysfunction in diabetic men: a Bayesian network meta-analysis of randomized controlled trials
Q53248622Comparison between subcutaneous injection of basic fibroblast growth factor-hydrogel and intracavernous injection of adipose-derived stem cells in a rat model of cavernous nerve injury.
Q53126992Comparison of efficacy for erectile function and lower urinary tract symptoms of tadalafil 20 mg on-demand and 5 mg once daily in patients with erectile dysfunction.
Q35201505Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies
Q42186099Comprehensive assessment of cavernosography with 320-row dynamic volume CT versus conventional cavernosography in erectile dysfunction patients caused by venous leakage
Q82596505Corpus cavernosum electromyography: could it be a parameter to predict ageing?
Q53241774Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients.
Q51646688Correlation Between the European System for Cardiac Operative Risk Evaluation and Sexual Function After Coronary Artery Bypass Graft Surgery
Q34161131Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction
Q37393314Cross-sectional study of male sexual function in bariatric patients
Q35384480Current Diagnosis and Management of Erectile Dysfunction
Q47707689Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study.
Q50682697Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with erectile dysfunction and coronary artery disease.
Q45964628Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status.
Q76321132Deep brain stimulation of the thalamus can influence penile erection
Q47876507Delivery of intracavernosal therapies using needle-free injection devices
Q38253049Diagnosing erectile dysfunction could save your patient's life
Q46571184Diagnostic value of nitric oxide, lipoprotein(a), and malondialdehyde levels in the peripheral venous and cavernous blood of diabetics with erectile dysfunction
Q44057013Dietary supplements and other alternative medicines for erectile dysfunction. What do I tell my patients?
Q45224129Difficulties in achieving vs maintaining erection: organic, psychogenic and relational determinants.
Q35563184Disorders of male sexual function
Q35924360Document for the general public. Spanish consensus panel on erectile dysfunction
Q51367455Effect of Ginkgo biloba Extract (EGb-761) on Recovery of Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rat Model.
Q93081459Effect of Nut Consumption on Erectile and Sexual Function in Healthy Males: A Secondary Outcome Analysis of the FERTINUTS Randomized Controlled Trial
Q35660091Effect of an Ethanol Extract of Scutellaria baicalensis on Relaxation in Corpus Cavernosum Smooth Muscle
Q46495805Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction
Q44362851Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction
Q38744754Effect of icariin in combination with daily sildenafil on penile atrophy and erectile dysfunction in a rat model of bilateral cavernous nerves injury
Q47394896Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats.
Q36247128Effect of sildenafil citrate on the cardiovascular system
Q33378219Effect of tadalafil on blood flow, pain, and function in chronic cold complex regional pain syndrome: a randomized controlled trial.
Q46746720Effects of androgen on the expression of vascular endothelial growth factor in the penile corpus cavernosum
Q64947373Effects of combined extracts of Lepidium meyenii and Allium tuberosum Rottl. on erectile dysfunction.
Q38606909Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure.
Q41099902Effects of insulin-like growth factor-1 on the relaxation responses of the cavernous smooth muscle from aged rats
Q36076581Effects of male silkworm pupa powder on the erectile dysfunction by chronic ethanol consumption in rats
Q33890190Effects of metformin on endothelial health and erectile dysfunction
Q43263739Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase
Q33629963Effects of the aqueous and hexane extracts of Mondia whitei on the sexual behaviour and some fertility parameters of sexually inexperienced male rats
Q34139231Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study
Q57059455Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: Protocol for a systematic review
Q91787573Efficacy and safety of an herbal formula (KBMSI-2) in the treatment of erectile dysfunction: A preliminary clinical study
Q38356574Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy
Q44054306Efficacy and safety of sildenafil in men with type 2 diabetes mellitus and erectile dysfunction
Q34231143Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials
Q24236046Efficacy and safety of vardenafil in men with diabetes and erectile dysfunction
Q24240809Efficacy and safety of vardenafil in men with diabetes and erectile dysfunction
Q35580626Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
Q34163836Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.
Q35038331Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction
Q46740992Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
Q57167048Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction
Q41891362Elective gangrene of the corpus spongiosum of idiopathic origin: A case report
Q92287415Embryonic stem cell-derived extracellular vesicle-mimetic nanovesicles rescue erectile function by enhancing penile neurovascular regeneration in the streptozotocin-induced diabetic mouse
Q38367700Emerging drugs for the treatment of erectile dysfunction
Q38028739Emerging tools for erectile dysfunction: a role for regenerative medicine.
Q37650850Endothelial dysfunction and erectile dysfunction in the aging man.
Q44085631Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation
Q46175834Endovascular therapy for vasculogenic erectile dysfunction
Q38297294Endovascular treatment of vasculogenic erectile dysfunction
Q24673071Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist
Q43985606Epidemiology and pathophysiology of male sexual dysfunction
Q36314038Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors
Q42805340Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension
Q61454282Erectile Dysfunction and Ischaemic Heart Disease
Q47937519Erectile Dysfunction and Sexual Hormone Levels in Men With Obstructive Sleep Apnea: Efficacy of Continuous Positive Airway Pressure
Q36932529Erectile Dysfunction in Male Survivors of Childhood Cancer-A Report From the Childhood Cancer Survivor Study
Q56966121Erectile dysfunction
Q62029106Erectile dysfunction
Q44739960Erectile dysfunction -- still a taboo subject
Q35130935Erectile dysfunction after surgical treatment
Q36628792Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference
Q37148383Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions
Q35087402Erectile dysfunction and diabetes
Q33710298Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
Q35977540Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment
Q35068163Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator
Q35572172Erectile dysfunction and vascular disease. What is the connection?
Q37776171Erectile dysfunction as a complication of heart failure
Q37058764Erectile dysfunction as a harbinger for increased cardiometabolic risk
Q36292416Erectile dysfunction as a marker for vascular disease
Q36359841Erectile dysfunction as an early sign of cardiovascular disease
Q33723290Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men.
Q38868978Erectile dysfunction in chronic renal failure patients undergoing hemodialysis in Egypt
Q47549053Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.
Q53104843Erectile dysfunction in myotonic dystrophy type 1 (DM1).
Q39732313Erectile dysfunction in patients with chronic viral liver disease: its relevance to protein malnutrition
Q36460243Erectile dysfunction in patients with liver disease related to chronic hepatitis B
Q37686844Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.
Q37109366Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial
Q38846229Erectile dysfunction patients are more satisfied with penile prosthesis implantation compared with tadalafil and intracavernosal injection treatments
Q28709383Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study
Q35720617Erectile dysfunction: etiology, evaluation, and treatment options
Q36016959Erectile dysfunction: interrelationship with the metabolic syndrome
Q35757438Erectile dysfunction: management update
Q35724843Erectile dysfunction: symptom or disease?
Q46437373Erectile dysfunction: to prescribe or not to prescribe?
Q42589268Erectile function in two-kidney, one-clip hypertensive rats is maintained by a potential increase in nitric oxide production
Q45194924Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial
Q50915038Erectogenic and Aphrodisiac Property of Moringa oleifera: Involvement of Soluble Epoxide Hydrolase Enzyme.
Q51250785Establishment of in vitro model of erectile dysfunction for the study of high-glucose-induced angiopathy and neuropathy.
Q35087516Etiology and treatment of erectile failure in diabetes mellitus
Q48526535European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted
Q48525600European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constitute
Q37930859Evaluation and treatment of erectile dysfunction in the aging male: a mini-review
Q91004871Evaluation of Sexual Dysfunction, Lower Urinary Tract Symptoms and Quality of Life in Men With Obstructive Sleep Apnea Syndrome and the Efficacy of Continuous Positive Airway Pressure Therapy
Q53727836Evaluation of arterial stiffness and cardiac function in patients with vascular erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil.
Q36020770Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction
Q44785618Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra
Q34586101Evaluations of erectile dysfunction before and after on-pump coronary artery bypass graft surgery
Q28566424Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile function
Q24655020Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling
Q90259886Extracorporeal Shock Waves Therapy Delivered by Aries Improves Erectile Dysfunction in Spontaneously Hypertensive Rats Through Penile Tissue Remodeling and Neovascularization
Q44764468Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan).
Q39305594Fingerroot, Boesenbergia rotunda and its Aphrodisiac Activity
Q35544101From molecules to mammals: what's NOS got to do with it?
Q35839488Future options for combination therapy in the management of erectile dysfunction in older men.
Q40286700Future strategies for treating erectile dysfunction.
Q36359862Gene and stem cell therapy for erectile dysfunction
Q37775988Gene therapy as future treatment of erectile dysfunction
Q45887184Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase
Q35633865Gene therapy treatments for erectile and bladder dysfunction
Q34707328Gene therapy: future therapy for erectile dysfunction
Q36310656Gene transfer for the therapy of erectile dysfunction: progress in the 21st century
Q57295893Genetic variation in the locus is associated with erectile dysfunction
Q46504484Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus.
Q37058005Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction
Q46145581Has prolactin a role in the hypogonadal status of HIV-infected patients?
Q33752567Hormonal profile, the PROGINS polymorphism, and erectile dysfunction complaints: data from a population-based survey
Q46055215Hot-stage microscopy for determination of API particles in a formulated tablet.
Q37582767How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors
Q90447541Human Tissue Kallikrein 1 Improves Erectile Dysfunction of Streptozotocin-Induced Diabetic Rats by Inhibition of Excessive Oxidative Stress and Activation of the PI3K/AKT/eNOS Pathway
Q37218153Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle.
Q36292445Hypogonadism in the man with erectile dysfunction: what to look for and when to treat
Q37810422Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know
Q55296399Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells.
Q53215865Impact of phosphodiesterase type 5 inhibitors on endothelial function.
Q36050766Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine production
Q37436962Impaired flow-mediated vasodilatation in Asian Indians with erectile dysfunction
Q37221821Improvement of erectile dysfunction by the active pepide from Urechis unicinctus by high temperature/pressure and ultra - wave assisted lysis in Streptozotocin Induced Diabetic Rats
Q37800121In Vitro and in Vivo Animal Models in Priapism Research
Q44085625Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users
Q39732295Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients
Q45051071Increased Risk for Cancer Following Erectile Dysfunction: A Nationwide Population-Based Follow-Up Study
Q39846013Increased Risk of Stroke Among Men with Erectile Dysfunction: A Nationwide Population-Based Study
Q37085194Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment
Q37961164Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men.
Q33854121Inhibition of Ninjurin 1 restores erectile function through dual angiogenic and neurotrophic effects in the diabetic mouse
Q48575928Insulin resistance is an independent predictor of erectile dysfunction in patients with gout.
Q44582259Internal pudendal artery stenoses and erectile dysfunction: Correlation with angiographic coronary artery disease
Q46422263Interstitial cells of Cajal in erectile dysfunction
Q42855656Intima‐media thickness of carotid arteries and erectile dysfunction in hemodialysis patients
Q42961704Intracavernosal administration of sodium nitrite as an erectile pharmacotherapy
Q47257811Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Erectile Dysfunction Following Cavernous Nerve Injury in Rats
Q46392332Introduction: Erectile dysfunction and cardiovascular risk factors
Q90452078Investigation of Interactive Activity of Electro-Acupuncture on Pharmacokinetics of Sildenafil and Their Synergistic Effect on Penile Blood Flow in Rats
Q36253972Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats
Q34983511Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function
Q39944599Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire
Q35643349Is erectile dysfunction a reliable indicator of general health status in men?
Q73837661Is erectile dysfunction the "tip of the iceberg" of a systemic vascular disorder?
Q50956102Is penile atherosclerosis the link between erectile dysfunction and cardiovascular risk? An autopsy study.
Q44023185Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction?
Q90576339Islet transplantation improved penile tissue fibrosis in a rat model of type 1 diabetes
Q48519012Levels of uric acid in erectile dysfunction of different aetiology.
Q50125343Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis
Q46456930Lithium decreased endothelium-mediated, but not nonadrenergic noncholinergic, relaxation of guinea pig corpus cavernosum in vitro: a role for nitrergic system
Q46930343Long-term effect of experimental hypercholesterolemia on cavernosal tissues
Q48662783Long-term outcomes of AMS Spectra® penile prosthesis implantation and satisfaction rates
Q43938749Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction
Q35007136Long-term treatment of clonidine, atenolol, amlodipine and dihydrochlorothiazide, but not enalapril, impairs the sexual function in male spontaneously hypertensive rats
Q46210987Lower Urinary Tract Symptoms, Erectile Dysfunction, and Quality of Life in Poststroke Men: A Controlled Cross-Sectional Study.
Q33289952Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment
Q37097048Lower urinary tract symptoms and sexual dysfunction: a common approach
Q80295789Lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 inhibitors
Q38220350Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?
Q36575478Male erectile dysfunction and microalbuminuria in adult nigerians with essential hypertension
Q36222944Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group
Q43973084Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies
Q34504227Management of erectile dysfunction secondary to treatment for localized prostate cancer
Q98784275Management of male sexual dysfunction after cancer treatment
Q37811488Medical Implications of Erectile Dysfunction
Q36181835Melanocortinergic control of penile erection
Q86975370Men with diabetes may require more aggressive treatment for erectile dysfunction
Q90071998Mesenchymal stem cell-derived exosomes ameliorate erection by reducing oxidative stress damage of corpus cavernosum in a rat model of artery injury
Q45863380Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction
Q64259298Meta-analysis of the efficacy of sexual intercourse for distal ureteric stones
Q44113058Metabolic syndrome: a potential and independent risk factor for erectile dysfunction in the Chinese male population
Q94453274Mitochondrial ATP synthase regulates corpus cavernosum smooth muscle cell function in vivo and in vitro
Q38118626Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction
Q37127318Molecular Yin and Yang of erectile function and dysfunction
Q33770111Molecular targets for diabetes mellitus-associated erectile dysfunction.
Q36464498Mouse model of erectile dysfunction due to diet-induced diabetes mellitus
Q47220920Multicenter pathophysiologic investigation of erectile dysfunction in clinic outpatients in China
Q37037517Multiple sclerosis and sexual dysfunction
Q47952917N-acetylcysteine Ameliorates the Erectile Dysfunction Caused by Chronic Intermittent Hypoxia in Rats: Partly Involvement of Endoplasmic Reticulum Stress
Q37890138Natural therapies used by adult men for the treatment of erectile dysfunction, benign prostatic hyperplasia, and for augmenting exercise performance
Q34471723Neurogenic erectile dysfunction
Q36824270Neurophysiological basis of penile erection
Q35569842New achievements and pharmacotherapeutic approaches to impotence in the elderly
Q37323289New horizons in erectile and endothelial dysfunction research and therapies
Q44507470New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction
Q35945247New treatment options for erectile dysfunction in patients with diabetes mellitus
Q35563945New treatments for erectile dysfunction
Q37881314Newer phosphodiesterase inhibitors: comparison with established agents
Q44748205Nitric oxide release from human corpus cavernosum induced by a purified scorpion toxin.
Q94400625Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea
Q46697840Normal erectile function
Q73485469Normal hemodynamic parameters do not always predict the presence of a rigid erection: a quantitative assessment of functional erectile impairment
Q37259276Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor?
Q64073912Ocimum gratissimum Linn. Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats
Q38158658Office-based management of impotence and Peyronie's disease
Q26747277Opportunities and challenges for direct C-H functionalization of piperazines
Q37886052Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: opening windows to enhanced sexual function and overall health
Q34279534Oral drug therapy for erectile dysfunction
Q80297898Oral pharmacotherapy and the contemporary evaluation and management of erectile dysfunction
Q45148792Overactive corpus cavernosum: a novel cause of erectile dysfunction
Q38232764Overview of the relevant literature on the possible role of acupuncture in treating male sexual dysfunction.
Q34706899Oxygen free radicals and the penis
Q37423701Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil
Q44212094Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction
Q34553453Penile erectile dysfunction after brachial plexus root avulsion injury in rats
Q46864671Penile erection requires association of soluble guanylyl cyclase with endothelial caveolin-1 in rat corpus cavernosum
Q44309222Penile neuronal nitric oxide synthase and its regulatory proteins are present in hypothalamic and spinal cord regions involved in the control of penile erection
Q47819112Penile neurovascular structure revisited: immunohistochemical studies with three-dimensional reconstruction.
Q37437009Penile prosthesis implantation in Chinese patients with severe erectile dysfunction: 10-year experience
Q37417114Penile rehabilitation following treatment for prostate cancer: an analysis of the current state of the art.
Q44991133Peripheral atherosclerosis in patients with arterial erectile dysfunction
Q45153798Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips.
Q41897333Pharmacological characterization of the relaxant effect induced by adrenomedullin in rat cavernosal smooth muscle
Q34106728Pharmacotherapy for erectile dysfunction
Q52682027Phosphodiesterase (PDE5) inhibition assay for rapid detection of erectile dysfunction drugs and analogs in sexual enhancement products.
Q34147460Phosphodiesterase 5 inhibitors: current status and potential applications
Q24246544Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
Q37848067Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions
Q35140096Phosphodiesterase type 5 (PDE5) inhibitors
Q37733556Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction
Q34987811Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction
Q35759044Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles.
Q38630414Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons
Q36206628Phosphodiesterase type 5 inhibitors for erectile dysfunction
Q36993658Phosphodiesterase type 5 inhibitors: state of the therapeutic class
Q36314042Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction
Q33818229Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism
Q36885422Physiological regulation of penile arteries and veins
Q35774866Physiology and biochemistry of erections
Q84970249Poly(ADP-Ribose) Polymerase Inhibition Improves Erectile Function in Diabetic Rats
Q64229328Positive Correlation between Left Hemisphere Lesion and Erectile Dysfunction in Post-Stroke Patients
Q26737724Postprostatectomy Erectile Dysfunction: A Review
Q36572595Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor
Q39636620Preclinical evidence for the benefits of penile rehabilitation therapy following nerve-sparing radical prostatectomy.
Q47905190Predictors of erectile function improvement in obstructive sleep apnea patients with long-term CPAP treatment
Q45017198Preserved fertility despite erectile dysfunction in mice lacking the nitric oxide receptor
Q78829145Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men
Q94922549Prevalence of Erectile Dysfunction in Patients with Diabetes Mellitus and Its Association with Body Mass Index and Glycated Hemoglobin in Africa: A Systematic Review and Meta-Analysis
Q40486793Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects
Q81004125Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients
Q58860233Prevalencia de disfunción eréctil en pacientes con hipertensión arterial
Q35763083Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I.
Q35763087Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II.
Q36628795Priapism: new concepts in the pathophysiology and new treatment strategies
Q38041867Priapism: pathophysiology and the role of the radiologist
Q64060510Prospective Study on Sexual Dysfunction in Male Chinese Liver Transplant Recipients
Q26746754Psychosexual disorders and dermatologists
Q37793997Recent Advances in the Medical and Surgical Treatment of Priapism
Q42952130Reduced Vasoreactivity in Corpus Cavernosum of the Akita Mouse
Q33506195Regulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management
Q50084511Relationship between oxidative stress and erectile function
Q46876200Relaxant effects of an alkaloid-rich fraction from Aspidosperma ulei root bark on isolated rabbit corpus cavernosum
Q33650796Research in pharmacotherapy for erectile dysfunction
Q40862954Risk factors for erectile dysfunction in patients with cardiovascular disease
Q35547102Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004
Q34020025Role of adenosine signaling in penile erection and erectile disorders
Q37948024Role of hydrogen sulfide in the physiology of penile erection
Q44690668Role of some vasoactive mediators in patients with erectile dysfunction: their relationship with angiotensin-converting enzyme and growth hormone
Q93056029S1P1 Gene Transfection Improves Erectile Function in Spontaneously Hypertensive Rats
Q36792665Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
Q53346874Salt-kneading: alternative sizing of active pharmaceutical ingredients?
Q47207449Screening for erectile dysfunction as part of periodic examination programs--concept and implementation
Q44363730Serum androgen levels in men: impact of health status and age.
Q53221201Severity of erectile dysfunction at presentation: effect of premature ejaculation and low desire.
Q35419887Sexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management
Q37409488Sexual dysfunction in multiple sclerosis
Q37849338Sexual evaluation and treatment of ageing males with haemophilia
Q36555652Sexual function after surgery for prostate or bladder cancer
Q48248664Sexual intercourse as a new option in the medical expulsive therapy of distal ureteral stones in males: a prospective, randomized, controlled study.
Q83929708Shared medical appointments in a pharmacy-based erectile dysfunction clinic
Q87378922Shengjing Capsule Improves Erectile Function Through Regulation of Nitric Oxide-induced Relaxation in Corpus Cavernosum Smooth Muscle in a Castrated Rat Model
Q36738144Short hairpin rna targeting insulin-like growth fator binding protein-3 restores the bioavailability of insulin-like growth factor-1 in diabetic rats
Q36056143Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.
Q45989350Sildenafil (Viagra) and club drug use in gay and bisexual men: the role of drug combinations and context.
Q32060378Sildenafil citrate: a therapeutic update
Q36572591Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction
Q45144066Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia
Q37151229Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study
Q35924319Specific aspects of erectile dysfunction in endocrinology
Q35924328Specific aspects of erectile function in urology/andrology
Q47887533Spontaneous Regeneration of Nerve Fiber and Irreversibility of Corporal Smooth Muscle Fibrosis after Cavernous Nerve Crush Injury: Evidence From Serial Transmission Electron Microscopy and Intracavernous Pressure
Q37078842Stem and endothelial progenitor cells in erection biology.
Q35737480Stem cell therapy for erectile dysfunction: a critical review
Q38148781Stem-cell therapy for erectile dysfunction.
Q44540739Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction.
Q42368368Surgical Techniques for Managing Post-prostatectomy Erectile Dysfunction
Q44376216Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial
Q36217695Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse
Q43778232Synergistic effects of sildenafil on relaxation of rabbit and rat cavernosal smooth muscles when combined with various vasoactive agents
Q43908604Tadalafil and vardenafil.
Q41978073Tadalafil in the treatment of erectile dysfunction
Q35827477Tadalafil pharmacokinetics in healthy subjects
Q33700805Target profiling of a small library of phosphodiesterase 5 (PDE5) inhibitors using chemical proteomics.
Q41153819Testosterone improves erectile function through inhibition of reactive oxygen species generation in castrated rats
Q37890133Testosterone replacement therapy in males with erectile dysfunction
Q35746088Thalamus and penile erection
Q60045178The 100 most influential manuscripts in andrology: a bibliometric analysis
Q38631968The Challenge of Erectile Dysfunction Management in the Young Man.
Q90520802The Combined Use of Stem Cells and Platelet Lysate Plasma for the Treatment of Erectile Dysfunction: A Pilot Study-6 Months Results
Q39067832The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review
Q33642022The Effect of Alcohol Administration on the Corpus Cavernosum.
Q36039353The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction.
Q41978840The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
Q36992225The GAy MEn Sex StudieS: erectile dysfunction among Belgian gay men
Q38479677The Old Made New: Natural Compounds against Erectile Dysfunction.
Q36530187The application of color Doppler flow imaging in the diagnosis and therapeutic effect evaluation of erectile dysfunction
Q53229012The associations among eNOS G894T gene polymorphism, erectile dysfunction and related risk factors.
Q73023984The clinical evaluation of common sexual concerns
Q43899123The clinical studies of sildenafil for the ageing male
Q48731350The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil
Q44449452The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model
Q49139040The effect of pelvic floor muscle training on sexual function in men with lower urinary tract symptoms after stroke
Q44306205The effect of periodontal treatment in improving erectile dysfunction: a randomized controlled trial
Q35827206The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.
Q36255181The efficacy and safety of PDE5 inhibitors
Q47866490The efficacy of udenafil in end-stage renal disease patients undergoing hemodialysis
Q41456612The evaluation of sexual dysfunction in male patients with migraine and tension type headache.
Q35073161The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction.
Q35186022The future is today: emerging drugs for the treatment of erectile dysfunction
Q33244595The hypoactive corpora cavernosa with degenerative erectile dysfunction: a new syndrome
Q43160861The impact of irritative lower urinary tract symptoms on erectile dysfunction in aging Taiwanese males.
Q35993845The impact of metabolic syndrome on retinal findings in patients with erectile dysfunction
Q44695350The impact of sildenafil citrate on sexual satisfaction profiles in men with a penile prosthesis in situ
Q47441673The impact of surgery for trochanteric femur fracture on sexuality in men and their female partners
Q90663802The link between periodontitis and erectile dysfunction: a review
Q35055194The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
Q45987400The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure.
Q36925283The quality of lifestyle and the quality of life
Q38907130The relation between erectile dysfunction and extent of coronary artery disease in the patients with stable coronary artery disease
Q93053492The relationship between erectile dysfunction and the Atherogenic Index of Plasma
Q37076223The relationship between resting heart rate variability and erectile tumescence among men with normal erectile function
Q34220107The relaxation effect and mechanism of action of higenamine in the rat corpus cavernosum
Q36009229The risk of erectile dysfunction in chronic obstructive pulmonary disease: a population-based cohort study in Taiwan
Q34635467The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Q74604281The role of melanocortins in body weight regulation: opportunities for the treatment of obesity
Q26823131The role of statins in erectile dysfunction: a systematic review and meta-analysis
Q36268301The supraspinal network in the control of erection
Q36291014The therapeutic dilemma: how to use psychotherapy
Q36255170The underlying pathophysiology and causes of erectile dysfunction
Q44428191The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction
Q41002184Thorax Computed Tomography Findings in Patients with Erectile Dysfunction.
Q36830299Tips and tricks on outpatient initiation and uptitration of beta-blockade in heart failure
Q35688181Topical alprostadil cream for the treatment of erectile dysfunction
Q44244655Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program
Q36307487Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors
Q36304785Treatment for erectile dysfunction based on patient-reported outcomes: to every man the PDE5 inhibitor that he finds superior
Q36116534Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function
Q46932537Treatment options for autonomic neuropathies
Q40352545Tyrosine-612 in PDE5 contributes to higher affinity for vardenafil over sildenafil
Q26851999Udenafil for the treatment of erectile dysfunction
Q28288359Udenafil: efficacy and tolerability in the management of erectile dysfunction
Q47444641Unreliability of the Duplex Scan in Diagnosing Corporeal Venous Occlusive Disease in Young Healthy Men With Erectile Deficiency
Q44306281Urological comorbidities in patients with rheumatoid arthritis : literature review
Q46407830Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy
Q44889724Use of intraurethral alprostadil in patients not responding to sildenafil citrate
Q38829614Usefulness of serum fetuin-A level as a marker of erectile dysfunction
Q37720731Validation of the International Index of Erectile Function (IIFE) for use in Brazil
Q45185326Vardenafil provides reliable efficacy over time in men with erectile dysfunction
Q35638042Vardenafil treatment for erectile dysfunction
Q35753433Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction
Q35592397Vardenafil: a review of its use in erectile dysfunction
Q51501668Vascular risk factors and erectile dysfunction in a cohort of healthy men.
Q36039557Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction?
Q34808639Viagra (sildenafil citrate) and ophthalmology
Q34329737What's new in urology
Q36359845Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem
Q46640327Yohimbine enhances the effect of sildenafil on erectile process in rats
Q80103350[Acute myocardial infarction associated to the Sildenafil consumption. A case report and review of the literature]
Q87333423[Conservative therapy of erectile dysfunction]
Q44267171[Erectile dysfunction]
Q87423281[Guidelines-oriented diagnostics of dyslipidemia]
Q84536917[Influence of aging on male sexual health]
Q87423401[Male sexuality in the elderly]
Q59238926‘Just Take Viagra’: Erectile Insurance, Prophylactic Certainty and Deficit Correction in Gay Men’s Accounts of Sexuopharmaceutical Use

Search more.